These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 26857129

  • 21. First report of Eucoleus boehmi (syn. Capillaria boehmi) in dogs in north-western Italy, with scanning electron microscopy of the eggs.
    Magi M, Guardone L, Prati MC, Torracca B, Macchioni F.
    Parasite; 2012 Nov; 19(4):433-5. PubMed ID: 23193529
    [Abstract] [Full Text] [Related]

  • 22. Intracranial migration of Eucoleus (Capillaria) boehmi in a dog.
    Clark AC, López FR, Levine JM, Cooper JJ, Craig TM, Voges AK, Johnson MC, Porter BF.
    J Small Anim Pract; 2013 Feb; 54(2):99-103. PubMed ID: 23146113
    [Abstract] [Full Text] [Related]

  • 23. The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in Europe.
    Hellmann K, Knoppe T, Radeloff I, Heine J.
    Parasitol Res; 2003 Jul; 90 Suppl 3():S142-3. PubMed ID: 12928883
    [No Abstract] [Full Text] [Related]

  • 24. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG, Davis WL, Jacobsen JA, Lewis VA, Settje TL.
    Vet Parasitol; 2015 May 30; 210(1-2):64-8. PubMed ID: 25801226
    [Abstract] [Full Text] [Related]

  • 25. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
    Taweethavonsawat P, Chungpivat S, Satranarakun P, Traub RJ, Schaper R.
    Parasitol Res; 2010 May 30; 106(6):1499-502. PubMed ID: 20349196
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs.
    Veronesi F, Di Cesare A, Braun G, Günther L, Morganti G, Rueca F, Petry G, Schaper R, Traversa D.
    Parasitol Res; 2017 Aug 30; 116(Suppl 1):65-74. PubMed ID: 28717949
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL, Kristensen AT, Jensen AL, Heine J, Koch J.
    Vet Parasitol; 2007 Jul 20; 147(3-4):258-64. PubMed ID: 17544583
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K, Heine J, Dumont P, Hellmann K.
    Parasitol Res; 2005 Oct 20; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.
    Segev G, Rojas A, Lavy E, Yaffe M, Aroch I, Baneth G.
    Parasit Vectors; 2018 Mar 05; 11(1):127. PubMed ID: 29506575
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
    Loft KE, Willesen JL.
    Vet Rec; 2007 Apr 14; 160(15):528-9. PubMed ID: 17435103
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical investigations and treatment outcome in a European wildcat (Felis silvestris silvestris) infected by cardio-pulmonary nematodes.
    Diakou A, Dimzas D, Astaras C, Savvas I, Di Cesare A, Morelli S, Neofitos Κ, Migli D, Traversa D.
    Vet Parasitol Reg Stud Reports; 2020 Jan 14; 19():100357. PubMed ID: 32057385
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
    Savadelis MD, Ohmes CM, Hostetler JA, Settje TL, Zolynas R, Dzimianski MT, Moorhead AR.
    Parasit Vectors; 2017 May 19; 10(1):245. PubMed ID: 28526088
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
    Genchi C, Genchi M, Petry G, Kruedewagen EM, Schaper R.
    Parasitol Res; 2013 Aug 19; 112 Suppl 1():81-9. PubMed ID: 23774842
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.